Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability

Journal of Bacteriology

Volumn 194, Issue 17, 2012, Pages 4709-4717

  Filkins, L M ^a   Hampton, T H ^a   Gifford, A H ^b   Gross, M J ^a   Hogan, D A ^a   Sogin, M L ^c   Morrison, H G ^c   Paster, B J ^d,e   O'Toole, G A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c MARINE BIOLOGICAL LABORATORY   (United States)

^d FORSYTH INSTITUTE   (United States)

^e HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S; TOBRAMYCIN;

ADULT; AMPLICON; ARTICLE; BACTERIUM DETECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; DNA DETERMINATION; DNA ISOLATION; FEMALE; GENE AMPLIFICATION; GENETIC ASSOCIATION; GENOME; HUMAN; HUMAN ORAL MICROBE IDENTIFICATION MICROARRAY; MALE; MICROARRAY ANALYSIS; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MOUTH CAVITY; OUTPATIENT CARE; PATIENT CARE; PATIENT STABILITY; POLYMERASE CHAIN REACTION; POLYMICROBIAL DIVERSITY; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PYROSEQUENCING; QUANTITATIVE POLYMERASE CHAIN REACTION; SPUTUM ANALYSIS; STREPTOCOCCUS; STREPTOCOCCUS MILLERI; STREPTOCOCCUS PARASANGUINIS; STREPTOCOCCUS SALIVARIUS;

ADULT; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; CYSTIC FIBROSIS; DNA, BACTERIAL; FEMALE; HUMANS; LUNG; MALE; METAGENOME; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; SPUTUM; STREPTOCOCCUS; TOBRAMYCIN; YOUNG ADULT;

BACTERIA (MICROORGANISMS); PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS; STREPTOCOCCUS MILLERI; STREPTOCOCCUS PARASANGUINIS; STREPTOCOCCUS SALIVARIUS;

EID: 84865781286     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00566-12     Document Type: Article

References (32)

1. Ahn J, et al. 2011. Oral microbiome profiles: 16S rRNA pyrosequencing and microarray assay comparison. PLoS One 6:e22788. doi:10.1371/journal.pone.0022788.
2. Bals R, Weiner DJ, Wilson JM. 1999. The innate immune system in cystic fibrosis lung disease. J. Clin. Invest. 103:303-307.
3. Bittar F, Rolain JM. 2010. Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients. Clin. Microbiol. Infect. 16:809-820.
4. Cox MJ, et al. 2010. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One 5:e11044. doi:10.1371/journal.pone.0011044.
5. Dodge JA, Lewis PA, Stanton M, Wilsher J. 2007. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur. Respir. J. 29:522-526.
6. Edgar RC. 2010. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26:2460-2461.
7. Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. 2011. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27:2194-2200.
8. Gifford AH, et al. 2011. Iron and CF-related anemia: expanding clinical and biochemical relationships. Pediatr. Pulmonol. 46:160-165.
9. Gilligan PH. 1991. Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev. 4:35-51.
10. Gomez MI, Prince A. 2007. Opportunistic infections in lung disease:Pseudomonas infections in cystic fibrosis. Curr. Opin. Pharmacol. 7:244-251.
11. Guss AM, et al. 2011. Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis. ISME J. 5:20-29.
12. Harris JK, et al. 2007. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc. Natl. Acad. Sci.U. S. A. 104:20529-20533.
13. Horz HP, Vianna ME, Gomes BP, Conrads G. 2005. Evaluation of universal probes and primer sets for assessing total bacterial load in clinical samples: general implications and practical use in endodontic antimicrobial therapy. J. Clin. Microbiol. 43:5332-5337.
14. Huse SM, et al. 2008. Exploring microbial diversity and taxonomy using SSU rRNA hypervariable tag sequencing. PLoS Genet. 4:e1000255. doi:10.1371/journal.pgen.1000255.
15. Lyczak JB, Cannon CL, Pier GB. 2002. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15:194-222.
16. Maeda H, et al. 2003. Quantitative real-time PCR using TaqMan and SYBR Green for Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, tetQ gene and total bacteria. FEMS Immunol.Med. Microbiol. 39:81-86.
17. Maeda Y, et al. 2011. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF). J. Cyst. Fibros. 10:133-139.
18. Parkins MD, Sibley CD, Surette MG, Rabin HR. 2008. The Streptococcus milleri group-an unrecognized cause of disease in cystic fibrosis: a case series and literature review. Pediatr. Pulmonol. 43:490-497.
19. Paster BJ, Dewhirst FE. 2009. Molecular microbial diagnosis. Periodontol.2000 51:38-44.
20. Paster BJ, Olsen I, Aas JA, Dewhirst FE. 2006. The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol.2000 42:80-87.
21. Picard FJ, et al. 2004. Use of tuf sequences for genus-specific PCR detection and phylogenetic analysis of 28 streptococcal species. J. Clin. Microbiol.42:3686-3695.
22. Rogers GB, et al. 2004. Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16S ribosomal DNA terminal restriction fragment length polymorphism profiling. J. Clin. Microbiol.42:5176-5183.
23. Rogers GB, et al. 2003. Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneityPCR and 16S rDNA terminal restriction fragment length polymorphism profiling. J. Clin. Microbiol. 41:3548-3558.
24. Rogers GB, et al. 2005. Bacterial activity in cystic fibrosis lung infections.Respir. Res. 6:49.
25. Rogers GB, et al. 2006. Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. J. Clin. Microbiol. 44:2601-2604.
26. Sibley CD, Rabin H, Surette MG. 2006. Cystic fibrosis: a polymicrobial infectious disease. Future Microbiol. 1:53-61.
27. Sibley CD, Parkins MD, Rabin HR, Surette MG. 2009. The relevance of the polymicrobial nature of airway infection in the acute and chroni cmanagement of patients with cystic fibrosis. Curr. Opin. Investig. Drugs10:787-794.
28. Sibley CD, et al. 2008. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc. Natl.Acad. Sci. U. S. A. 105:15070-15075.
29. Sogin ML, et al. 2006. Microbial diversity in the deep sea and the underexplored rare biosphere. Proc. Natl. Acad. Sci. U. S. A. 103:12115-12120.
30. Stressmann FA, et al. 2011. Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation? J. Cyst. Fibros. 10:357-365.
31. Tunney MM, et al. 2008. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am. J. Respir. Crit. Care Med.177:995-1001.
32. Zhao J, et al. 26 March 2012. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc. Natl. Acad. Sci. U. S. A. [Epub ahead of print.] doi:10.1073/pnas.1120577109.